Menu
Back to Archived Journals » Core Evidence » Volume 7 » default
Core Evidence ceased publishing in January 2023. All articles that have been published in Core Evidence will continue to be available on the Dove Press site, and will be securely archived with CLOCKSS.
Core Evidence
ISSN: 1555-175X
- View all (143)
- Volume 15, 2020 (4)
- Volume 14, 2019 (6)
- Volume 13, 2018 (3)
- Volume 12, 2017 (2)
- Volume 11, 2016 (5)
- Volume 10, 2015 (9)
- Volume 9, 2014 (13)
- Volume 8, 2013 (7)
- Volume 7, 2012 (12)
- Volume 6, 2011 (7)
- Volume 5, 2010 (9)
- Volume 4, 2009 (20)
- Volume 3, 2008 (5)
- Volume 2, 2007 (22)
- Volume 1-Issues 3 & 4, 2006 (8)
- Volume 1-Issues 1 & 2, 2005 (11)
Archive: Volume 7, 2012
An evidence-based review of linezolid for the treatment of methicillin-resistant Staphylococcus aureus (MRSA): place in therapy
Watkins RR, Lemonovich TL, File Jr TM
Core Evidence 2012, 7:131-143
Published Date: 11 December 2012
Polifeprosan 20, 3.85% carmustine slow-release wafer in malignant glioma: evidence for role in era of standard adjuvant temozolomide
Kleinberg L
Core Evidence 2012, 7:115-130
Published Date: 26 October 2012
An evidence-based review of the potential role of icatibant in the treatment of acute attacks in hereditary angioedema type I and II
Floccard B, Hautin E, Bouillet L, Coppere B, Allaouchiche B
Core Evidence 2012, 7:105-114
Published Date: 27 September 2012
Rindopepimut: an evidence-based review of its therapeutic potential in the treatment of EGFRvIII-positive glioblastoma
Babu R, Adamson DC
Core Evidence 2012, 7:93-103
Published Date: 14 September 2012
Pancrelipase: an evidence-based review of its use for treating pancreatic exocrine insufficiency
Nakajima K, Oshida H, Muneyuki T, Kakei M
Core Evidence 2012, 7:77-91
Published Date: 19 July 2012
Colesevelam hydrochloride: evidence for its use in the treatment of hypercholesterolemia and type 2 diabetes mellitus with insights into mechanism of action
Zema MJ
Core Evidence 2012, 7:61-75
Published Date: 12 July 2012
An evidence-based review of apixaban and its potential in the prevention of stroke in patients with atrial fibrillation
Deedwania P, Huang GW
Core Evidence 2012, 7:49-59
Published Date: 9 July 2012
Linaclotide: evidence for its potential use in irritable bowel syndrome and chronic constipation
Lee N, Wald A
Core Evidence 2012, 7:39-47
Published Date: 25 June 2012
Mipomersen: evidence-based review of its potential in the treatment of homozygous and severe heterozygous familial hypercholesterolemia
Parhofer KG
Core Evidence 2012, 7:29-38
Published Date: 31 May 2012
Dapagliflozin: an evidence-based review of its potential in the treatment of type-2 diabetes
Chao EC
Core Evidence 2012, 7:21-28
Published Date: 1 June 2012
An evidence-based review of the potential benefits of taliglucerase alfa in the treatment of patients with Gaucher disease
Hollak CE
Core Evidence 2012, 7:15-20
Published Date: 4 May 2012
Dapoxetine: an evidence-based review of its effectiveness in treatment of premature ejaculation
McCarty EJ, Dinsmore WW
Core Evidence 2012, 7:1-14
Published Date: 19 January 2012